Categories: Wire Stories

Juniper Research: Security Information & Event Management Spend to Exceed $6.4 Billion by 2027 Globally, as IBM, Rapid7 & Splunk Lead the Market

BASINGSTOKE, England–(BUSINESS WIRE)–#siemdata–A new study from Juniper Research has found that the total business spend on SIEM (Security Identity & Event Management) will exceed $6.4 billion globally by 2027, from just over $4.4 billion in 2022. It predicts that this growth of 45% will be driven by the transition from term licence (where businesses can use SIEM for specific licence lengths) to more flexible SaaS (Software-as-a-Service) models (where SIEM solutions are purchased via monthly subscription). This will enable small businesses to access previously unaffordable services.

A SIEM system is a combination of SIM (Security Information Management) & SEM (Security Event Management), which results in real-time automated analysis of security alerts generated by applications and network hardware; leading to improved corporate cybersecurity.

IBM Tops Juniper Research Competitor Leaderboard

The research identified the world�s leading SIEM providers by evaluating their offerings, and the key factors that have led to their respective success, such as the breadth and depth of their platforms.

The top 3 vendors are:

  1. IBM
  2. Rapid7
  3. Splunk

Research co-author Nick Maynard explained further: “Juniper Research has ranked IBM as leading in the global SIEM market, based on its highly successful analytics platform and its ease of integration. SIEM vendors aiming to compete must design scalable solutions that are accessible to smaller businesses, which can provide easy-to-understand, actionable insights for less experienced cybersecurity teams.”

Transition to SaaS Accelerating Rapidly

Additionally, the research found that SaaS business models within SIEM are gaining traction; accounting for almost 73% of global business spend on SIEM in 2027, from only 37% in 2022. This significant increase represents an opportunity for newer vendors to break into the market with appealing SaaS-based models, but SIEM vendors must be careful not to leave larger enterprises, which still prefer term licences, behind.

View the SIEM market research: https://www.juniperresearch.com/researchstore/key-vertical-markets/security-information-event-research-report

Download the whitepaper: https://www.juniperresearch.com/whitepapers/why-siem-is-critical-to-cybersecurity-processes

Juniper Research provides research and analytical services to the global hi-tech communications sector; providing consultancy, analyst reports, and industry commentary.

Contacts

Sam Smith, Press Relations

T: +44(0)1256 830002

E: sam.smith@juniperresearch.com

Alex

Recent Posts

Getting Ready: LUX Helps Female Ex-Offenders Reintegrate Back to Society

LUX Launches ‘Getting Ready’ Campaign to Inspire Ex-offenders to Re-embrace Beauty and Re-enter Society with…

48 mins ago

PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA

SEOUL, South Korea--(BUSINESS WIRE)--#AcuteMyeloidLeukemia--PROTEINA announced today that it has held a kickoff meeting with Professor…

1 hour ago

Nordson Electronics Solutions Receives EM China Innovation Award for the New ASYMTEK Select Coat® SL-1040 Conformal Coating System

Recognized at the Productronica China tradeshow, the SL-1040 elevates coating performance with improved yield and…

3 hours ago

Hong Kong Ups the Game with New Incentive Playbook

Largest Celebration Ever with Over 110 Agents from Eight Markets to Experience Ultimate Hong Kong…

3 hours ago

DTEN’s Next Generation Video Conferencing and Collaboration Device for Zoom and Microsoft Teams, Now available in South Korea

DTEN’s Flagship D7X All-in-One Solution is Now KC and KCC Certified in South Korea, Delivering…

4 hours ago

AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)

SEONGNAM-SI, South Korea--(BUSINESS WIRE)--AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA)…

5 hours ago